Single-pill treatment proves as effective at suppressing virus as multi-pill therapy, while long-acting preventive injections ...

Today, advancements in medicine have rendered HIV a manageable condition that allows most individuals to enjoy a typical ...

Nearly 20 states are moving to restrict assistance programs that help people afford HIV medications and treatment.

Although HIV infection remains a global public health challenge, ART has transformed it from a fatal illness to a manageable lifetime condition for those who are successfully being treated.Initially, ...

Transmission electron micrograph showing hepatitis B virus particles (colored orange). The Johns Hopkins Medicine-led ...

It's designed to take the place of complicated, multiple drug regimens that many people with HIV need to follow. And it's ...

Modern HIV treatment is one of medicine's great success stories. With today's therapies, many people living with HIV can ...

Vaccine development remains central to reducing incident HIV globally, particularly where long-acting PrEP access is limited, with therapeutic and preventive approaches advancing in parallel.

A large international clinical trial has unveiled a promising new option for people living with highly treatment-resistant ...

Merck said a treatment it is developing for HIV-1 met its primary endpoint in three Phase 3 trials. The biopharmaceutical company said Wednesday the results add to growing evidence for ...

Three experimental injectable antiretrovirals – a novel capsid inhibitor and two next-generation integrase inhibitors – could ...